Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.03 | 13.02 | 12.21 | 11.89 | 13.30 | 12.68 | 12.32 | 10.85 | 12.93 | 12.29 | 11.40 | 9.00 |
| Expenses | 11.48 | 12.18 | 11.20 | 11.81 | 11.64 | 11.60 | 11.27 | 10.86 | 11.03 | 11.16 | 10.66 | 9.49 |
| Operating Profit | 0.55 | 0.84 | 1.01 | 0.08 | 1.66 | 1.08 | 1.05 | -0.01 | 1.90 | 1.13 | 0.74 | -0.49 |
| OPM % | 4.57% | 6.45% | 8.27% | 0.67% | 12.48% | 8.52% | 8.52% | -0.09% | 14.69% | 9.19% | 6.49% | -5.44% |
| Other Income | 0.08 | 0.08 | 0.08 | 0.07 | 0.08 | 0.07 | 0.09 | 0.09 | 0.05 | 0.13 | -0.37 | 0.48 |
| Interest | 0.20 | 0.16 | 0.15 | 0.13 | 0.13 | 0.08 | 0.07 | 0.05 | 0.07 | 0.04 | 0.03 | 0.03 |
| Depreciation | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.13 | 0.11 |
| Profit before tax | 0.34 | 0.67 | 0.85 | -0.07 | 1.52 | 0.97 | 0.97 | -0.07 | 1.78 | 1.12 | 0.21 | -0.15 |
| Tax % | 0.00% | 0.00% | 35.29% | 14.29% | 1.97% | -3.09% | 449.48% | -42.86% | 21.35% | 33.04% | 47.62% | 20.00% |
| Net Profit | 0.33 | 0.67 | 0.54 | -0.08 | 1.48 | 1.01 | -3.39 | -0.04 | 1.40 | 0.76 | 0.10 | -0.18 |
| EPS in Rs | 0.44 | 0.90 | 0.73 | -0.11 | 1.99 | 1.36 | -4.57 | -0.05 | 1.89 | 0.98 | 0.13 | -0.23 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.00 | 25.29 | 29.01 | 31.03 | 37.54 | 25.18 | 40.13 | 46.78 | 47.92 | 50.20 | 47.47 | 45.62 |
| Expenses | 24.84 | 25.21 | 28.68 | 30.54 | 36.86 | 27.77 | 39.02 | 48.94 | 46.65 | 46.31 | 43.71 | 42.34 |
| Operating Profit | 0.16 | 0.08 | 0.33 | 0.49 | 0.68 | -2.59 | 1.11 | -2.16 | 1.27 | 3.89 | 3.76 | 3.28 |
| OPM % | 0.64% | 0.32% | 1.14% | 1.58% | 1.81% | -10.29% | 2.77% | -4.62% | 2.65% | 7.75% | 7.92% | 7.19% |
| Other Income | 0.19 | 0.44 | 0.41 | 0.32 | 0.29 | 0.62 | 0.31 | 0.35 | 0.32 | 0.31 | -0.12 | 0.29 |
| Interest | 0.38 | 0.31 | 0.23 | 0.25 | 0.29 | 0.39 | 0.40 | 0.72 | 0.68 | 0.42 | 0.18 | 0.17 |
| Depreciation | 0.19 | 0.19 | 0.19 | 0.21 | 0.24 | 0.18 | 0.28 | 0.36 | 0.37 | 0.38 | 0.42 | 0.44 |
| Profit before tax | -0.22 | 0.02 | 0.32 | 0.35 | 0.44 | -2.54 | 0.74 | -2.89 | 0.54 | 3.40 | 3.04 | 2.96 |
| Tax % | 209.09% | 150.00% | 15.62% | -25.71% | 36.36% | -0.39% | -17.57% | -42.21% | 55.56% | 128.53% | 27.30% | |
| Net Profit | -0.67 | -0.01 | 0.27 | 0.43 | 0.28 | -2.52 | 0.87 | -1.67 | 0.24 | -0.98 | 2.20 | 2.08 |
| EPS in Rs | -0.90 | -0.01 | 0.36 | 0.58 | 0.38 | -3.40 | 1.17 | -2.25 | 0.32 | -1.32 | 2.82 | 2.77 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 7% | 14% | 0% | -7% | ||
| Compounded Profit Growth | 19% | 25% | 51% | 336% | ||
| Stock Price CAGR | 16% | 21% | 16% | -8% | ||
| Return on Equity | -1% | 2% | 8% | 30% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.79 |
| Reserves | 3.61 | 2.94 | 2.64 | 2.98 | 3.41 | 3.69 | 0.24 | 1.11 | -0.56 | -0.31 | -0.94 | 1.94 |
| Borrowings | 8.21 | 7.13 | 7.00 | 0.37 | 0.68 | 2.60 | 4.74 | 6.67 | 7.27 | 3.87 | 0.94 | 1.30 |
| Other Liabilities | 7.06 | 6.98 | 6.59 | 8.69 | 7.94 | 8.80 | 9.47 | 12.19 | 14.39 | 12.29 | 15.41 | 13.52 |
| Total Liabilities | 26.30 | 24.47 | 23.65 | 19.46 | 19.45 | 22.51 | 21.87 | 27.39 | 28.52 | 23.27 | 22.83 | 24.55 |
| Fixed Assets | 6.48 | 6.34 | 6.17 | 1.88 | 2.06 | 2.29 | 2.45 | 4.29 | 3.99 | 3.69 | 3.65 | 3.25 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.30 | 0.30 | 0.24 | 0.27 | 0.29 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.52 | 1.35 |
| Other Assets | 19.52 | 17.83 | 17.24 | 17.31 | 17.10 | 19.95 | 19.15 | 22.83 | 24.26 | 19.31 | 18.66 | 19.95 |
| Total Assets | 26.30 | 24.47 | 23.65 | 19.46 | 19.45 | 22.51 | 21.87 | 27.39 | 28.52 | 23.27 | 22.83 | 24.55 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1.38 | 0.16 | 0.24 | 4.58 | -0.61 | -1.59 | -0.16 | -0.44 | 0.03 | 2.60 | 3.06 | 1.71 |
| Cash from Investing Activity | 0.08 | -0.13 | 0.18 | 1.11 | -0.13 | -0.27 | -0.42 | -0.87 | 0.62 | -0.46 | 0.46 | -0.11 |
| Cash from Financing Activity | -0.73 | -1.43 | -0.36 | -5.39 | 0.20 | 1.72 | 1.83 | 1.53 | -0.12 | -4.08 | -2.83 | 0.47 |
| Net Cash Flow | 0.73 | -1.39 | 0.06 | 0.29 | -0.55 | -0.14 | 1.24 | 0.22 | 0.52 | -1.94 | 0.69 | 2.08 |
| Free Cash Flow | 0.92 | 0.10 | 0.23 | 4.45 | -1.01 | -2.07 | -0.66 | -2.55 | -0.03 | 2.53 | 3.41 | 1.69 |
| CFO/OP | 191% | 406% | 688% | 1,418% | -98% | -219% | 0% | -31% | -3% | 205% | 81% | 45% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 126.81 | 123.81 | 114.31 | 57.62 | 53.29 | 68.16 | 74.94 | 49.75 | 62.34 | 43.11 | 36.86 | 37.45 |
| Inventory Days | 142.73 | 162.86 | 150.01 | 126.33 | 114.69 | 90.00 | 136.65 | 153.90 | 83.56 | 81.09 | 70.81 | 79.43 |
| Days Payable | 88.41 | 92.30 | 59.70 | 110.67 | 85.26 | 83.44 | 104.13 | 96.22 | 110.35 | 97.39 | 69.65 | 33.65 |
| Cash Conversion Cycle | 181.14 | 194.37 | 204.61 | 73.29 | 82.72 | 74.72 | 107.46 | 107.43 | 35.56 | 26.81 | 38.02 | 83.23 |
| Working Capital Days | 97.04 | 110.52 | 86.74 | 20.89 | 27.88 | 25.18 | -14.06 | 6.82 | -20.21 | -7.69 | -13.89 | -5.77 |
| ROCE % | 3.39% | 0.87% | 1.91% | 2.95% | 5.39% | 5.79% | -15.09% | 8.26% | -14.80% | 9.72% | 41.41% | 39.24% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 36.78% | 37.01% | 37.03% | 37.03% | 37.03% | 37.03% | 37.03% | 37.03% | 37.03% | 40.03% | 40.03% | 40.03% |
| Public | 63.22% | 62.99% | 62.97% | 62.97% | 62.97% | 62.97% | 62.99% | 62.96% | 62.97% | 59.98% | 59.97% | 59.98% |
| No. of Shareholders | 13,404 | 13,327 | 13,203 | 13,394 | 13,538 | 13,710 | 13,764 | 13,804 | 13,812 | 13,805 | 13,750 | 13,755 |
Fundamentals
Market Cap₹ 29.6 Cr.
Current Price₹ 38.0
Stock P/E13.3
Book Value₹ 12.5
ROCE39.2 %
ROE30.2 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-7%
Compounded Profit Growth (TTM)336%
Standalone figures.
Valuation
Market capRs 27 Cr
Enterprise valueRs 26 Cr
P/E (TTM)13.17x
Price to book2.82x
Price to sales0.60x
EV / EBITDA7.24x
EV / EBIT8.25x
EV / sales0.57x
Price to cash flow16.02x
Earnings yield7.59%
P/E, 3-year average87.33x
P/B, 3-year average5.00x
P/E, 5-year average65.65x
P/B, 5-year average3.82x
Profitability
Operating margin (excl. other income)7.92%
Operating margin (incl. other income)7.67%
EBITDA margin7.83%
Pre-tax margin6.49%
Net profit margin4.56%
Net margin, latest quarter-2.00%
ROE27.14%
ROCE34.91%
ROA9.29%
ROE, 3-year average5.39%
ROCE, 3-year average28.71%
ROA, 3-year average1.99%
ROE, 5-year average1.04%
ROCE, 5-year average15.92%
ROA, 5-year average0.70%
ROIC (approx.)27.85%
Tax rate27.30%
Other income / net worth-1.23%
Growth
Sales growth (latest year)-5.44%
Sales CAGR, 3 years0.49%
Sales CAGR, 5 years13.52%
Sales growth QoQ-21.05%
Profit growth QoQ-280.00%
Sales growth YoY (latest quarter)-17.05%
Per share
EPS (TTM)Rs 2.67
EPS (latest year)Rs 2.82
EPS (latest quarter)Rs -0.23
EPS, 3-year averageRs 0.61
EPS, 5-year averageRs 0.15
Book value per shareRs 12.49
Sales per shareRs 58.55
Cash flow per shareRs 2.19
Free cash flow per shareRs 2.17
Efficiency
Asset turnover1.93x
Fixed asset turnover14.61x
Inventory turnover4.82x
Inventory days76 days
Debtor days37 days
Debtors turnover9.75x
Creditor days34 days
Cash conversion cycle83 days
Working capital days-6 days
Leverage
Total debtRs 1 Cr
Cash and bankRs 3 Cr
Net debtRs -2 Cr
Debt to equity0.13x
Net debt / EBITDA-0.44x
Interest coverage18.41x
Owners' fund to total sources39.63%
Debt to assets5.30%
Cash flow
Cash from Operating Activity (latest year)Rs 2 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs 0 Cr
Net Cash Flow (latest year)Rs 2 Cr
Free cash flow (latest year)Rs 2 Cr
FCFE (approx.: FCF + change in debt)Rs 2 Cr
Cash from ops / profit, 5 years10.55x
Sales to cash flow27.76x
Statement figures
Net sales (TTM)Rs 46 Cr
Net sales (latest year)Rs 47 Cr
Sales (latest quarter)Rs 9 Cr
Operating profit excl. other income (latest year)Rs 4 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 4 Cr
PBDT (TTM)Rs 3 Cr
Profit before tax (TTM)Rs 3 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 2 Cr
Net profit (latest year)Rs 2 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 18 Cr
Total expenditure (latest year)Rs 44 Cr
Total income (latest year)Rs 47 Cr
Share capitalRs 8 Cr
ReservesRs 2 Cr
Shareholders' fundsRs 10 Cr
Total assetsRs 25 Cr
Net blockRs 3 Cr
InvestmentsRs 1 Cr
ReceivablesRs 5 Cr
InventoryRs 4 Cr
Other liabilitiesRs 14 Cr
Shares outstanding (crore)0.78
Ownership
Promoter holding40.03% (+3.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 13.2 is at the 12th percentile of its own 5.4-year range
(median 19.8, low 10.9, high 275.4).
P/B 2.82 is at the 62th percentile (median 1.62).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 524314 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -2.4% | -2.8% | +0.4 pts |
| 1 month | -7.4% | -6.8% | -0.6 pts |
| 3 months | -1.8% | -7.6% | +5.9 pts |
| 3 years | +40.6% | +14.2% | +26.4 pts |
| 5 years | +134.4% | +27.9% | +106.5 pts |
Red flags
F-score 4 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹9 Cr -17.1% vs Jun 2025.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Gujarat Terce Laboratories Ltd?
Gujarat Terce Laboratories Ltd (524314) has a market capitalisation of Rs 29.6 Cr. at the 2026-10-01 close.
What is the P/E ratio of Gujarat Terce Laboratories Ltd?
Gujarat Terce Laboratories Ltd trades at a P/E of 13.3 on trailing twelve-month profit, at the 2026-10-01 close.
What were Gujarat Terce Laboratories Ltd's latest quarterly results?
In the Jun 2026 quarter, Gujarat Terce Laboratories Ltd sales was Rs 9 Cr (-17.1% vs Jun 2025) with a net loss of Rs 0 Cr.